- Home
- LXEO vs AMRN Comparison
LXEO vs AMRN Comparison
Compare LXEO & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXEO
- AMRN
- Stock Information
- Founded
- LXEO 2017
- AMRN 1989
- Country
- LXEO United States
- AMRN Ireland
- Employees
- LXEO N/A
- AMRN N/A
- Industry
- LXEO
- AMRN Biotechnology: Pharmaceutical Preparations
- Sector
- LXEO
- AMRN Health Care
- Exchange
- LXEO Nasdaq
- AMRN Nasdaq
- Market Cap
- LXEO 140.6M
- AMRN 189.2M
- IPO Year
- LXEO 2023
- AMRN 1993
- Fundamental
- Price
- LXEO $2.97
- AMRN $0.41
- Analyst Decision
- LXEO Strong Buy
- AMRN Buy
- Analyst Count
- LXEO 5
- AMRN 1
- Target Price
- LXEO $23.80
- AMRN N/A
- AVG Volume (30 Days)
- LXEO 475.1K
- AMRN 1.8M
- Earning Date
- LXEO 03-18-2025
- AMRN 03-12-2025
- Dividend Yield
- LXEO N/A
- AMRN N/A
- EPS Growth
- LXEO N/A
- AMRN N/A
- EPS
- LXEO N/A
- AMRN N/A
- Revenue
- LXEO N/A
- AMRN $228,614,000.00
- Revenue This Year
- LXEO N/A
- AMRN N/A
- Revenue Next Year
- LXEO N/A
- AMRN N/A
- P/E Ratio
- LXEO N/A
- AMRN N/A
- Revenue Growth
- LXEO N/A
- AMRN N/A
- 52 Week Low
- LXEO $2.32
- AMRN $0.35
- 52 Week High
- LXEO $19.50
- AMRN $1.11
- Technical
- Relative Strength Index (RSI)
- LXEO 37.57
- AMRN 26.95
- Support Level
- LXEO $2.51
- AMRN $0.35
- Resistance Level
- LXEO $2.95
- AMRN $0.55
- Average True Range (ATR)
- LXEO 0.34
- AMRN 0.05
- MACD
- LXEO 0.07
- AMRN -0.02
- Stochastic Oscillator
- LXEO 40.88
- AMRN 24.00
About LXEO Lexeo Therapeutics Inc.
Lexeo Therapeutics Inc is a a clinical-stage genetic medicines company dedicated to transforming healthcare by applying pioneering science to fundamentally change how disease is treated. Its pipeline consists of candidates targeting patient populations that place significant burden on society and are most amenable to their genetic medicine approach. The Company is focused on preclinical and clinical stage gene therapies, and specifically on hereditary and acquired diseases of high unmet need which is their only business segment.
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.